title: Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions.
abstract: The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis.
authors.affiliation: Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia, Spain. rcervera@clinic.ub.es
authors.forename: R
authors.initials: R
authors.lastname: Cervera
authors.forename: M G
authors.initials: MG
authors.lastname: Tektonidou
authors.forename: G
authors.initials: G
authors.lastname: Espinosa
authors.forename: A R
authors.initials: AR
authors.lastname: Cabral
authors.forename: E B
authors.initials: EB
authors.lastname: González
authors.forename: D
authors.initials: D
authors.lastname: Erkan
authors.forename: S
authors.initials: S
authors.lastname: Vadya
authors.forename: H E
authors.initials: HE
authors.lastname: Adrogué
authors.forename: M
authors.initials: M
authors.lastname: Solomon
authors.forename: G
authors.initials: G
authors.lastname: Zandman-Goddard
authors.forename: Y
authors.initials: Y
authors.lastname: Shoenfeld
mesh_terms: D026683:Advisory Committees; D017152:Antibodies, Antiphospholipid / Q000009:adverse effects; D016736:Antiphospholipid Syndrome / Q000145:classification / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D003226:Congresses as Topic; D032921:Consensus; D005260:Female; D017408:Guidelines as Topic; D006351:Heart Valves / Q000002:abnormalities / Q000473:pathology*; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D011247:Pregnancy; D013781:Texas
chemical_list: D017152:Antibodies, Antiphospholipid